| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 18,580 | 18,662 | 11.11. | |
| 18,590 | 18,672 | 11.11. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 18,988 | 9.000 | |||
| 18,936 | 512 | |||
| 18,930 | 4.500 | |||
| 18,928 | 999 | |||
| 18,890 | 159 | |||
| 18,884 | 4.500 | |||
| 18,850 | 512 | |||
| 18,846 | 512 | |||
| 18,804 | 512 | |||
| 18,802 | 1.800 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/via.htm [/URL] | ||||
| 1.412 | 18,740 | |||
| 450 | 18,662 | |||
| 2.000 | 18,658 | |||
| 4.500 | 18,630 | |||
| 9.000 | 18,612 | |||
| 432 | 18,556 | |||
| 9.000 | 18,518 | |||
| 432 | 18,510 | |||
| 2 | 18,494 | |||
| 1.302 | 18,436 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 28.530 | 0,806 | 23.006 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 15:05:41 | 18,396 | 6 |
| 14:13:41 | 18,578 | 14 |
| 14:13:41 | 18,602 | 54 |
| 13:21:36 | 18,862 | 557 |
| 09:22:25 | 18,452 | 14 |
| Tagesumsatz Xetra | +0,078 +0,43 % | 691 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | Viatris (NDQ:VTRS): Meet The Company Behind Viagra! But Can Yesterday's Blockbuster Still Build Tommorrow's Returns and How? | 11 | Stocks Down Under | ||
| VIATRIS Aktie jetzt für 0€ handeln | |||||
| Fr | Jefferies raises Viatris stock price target to $22 on guidance lift | 17 | Investing.com | ||
| Fr | Jefferies hebt Kursziel für Viatris nach Prognoseanhebung auf 22 US-Dollar an | 27 | Investing.com Deutsch | ||
| 05.11. | Viatris signals low to mid-single-digit growth in Greater China for 2027 while targeting $50M+ Pacira cost synergies by end of 2028 | 10 | Seeking Alpha | ||
| 05.11. | Viatris Q3 2026 Earnings Call Transcript | 14 | Benzinga.com |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mi | Novo Nordisk A/S: Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care | GlobeNewswire (Europe) | Bagsværd, Denmark, 11 November 2026 - Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027-2036. Announced ahead of World Diabetes Day (14 November)... ► Artikel lesen | |
| Mi | JEFFERIES stuft NOVARTIS AG auf 'Hold' | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Novartis auf "Hold" mit einem Kursziel von 125 Franken belassen. Trotz einiger Flops in der Entwicklungs-Pipeline der Schweizer... ► Artikel lesen | |
| Mi | Teva Pharmaceutical Industries Ltd: Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6-7 Billion in Innovative Medicines Revenue by 2030 | GlobeNewswire (Europe) | The Company has more than doubled revenue from innovative medicines since launching Pivot to Growth in 2023, demonstrating sustained execution and the growing strength of its high-velocity biopharma... ► Artikel lesen | |
| Mi | Boehringer Ingelheim: The savings that cost more: new report puts a number on Europe's innovation choice | GlobeNewswire (Europe) | This release is intended for the general public, healthcare professionals, policymakers and other healthcare decision-makers, plus pharmaceutical, policy and trade media.
New analysis of five EU... ► Artikel lesen | |
| Mi | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.11.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.11.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.11.2026.ISIN NameAU000000SXL4 SOUTHERN... ► Artikel lesen |